Development and Application of Organic Sonosensitizers in Cancer Therapy
This review provides a comprehensive overview of organic sonosensitizers employed in cancer treatment, describing their underlying mechanisms and structure‐activity relationship in terms of sonodynamic therapy. The significance of nanotechnology and combination therapy with other oncological modalities (photothermal therapy, photodynamic therapy, etc.)
Yuhan Ding+5 more
wiley +1 more source
Lupenone preserves T cell activity by recovery of CD40L expression and protection from cytotoxicity due to methamphetamine exposure. [PDF]
Lee HS, Kim EN, Jeong GS.
europepmc +1 more source
iPRISM: Intelligent Predicting Response to Cancer Immunotherapy through Systematic Modeling
The Intelligent Predicting Response to cancer Immunotherapy through Systematic Modeling (iPRISM) model uses data from genes and immune responses to predict how well cancer patients will respond to immunotherapy. Tested on multiple cancer types, iPRISM shows higher accuracy compared to existing methods.
Yinchun Su+7 more
wiley +1 more source
Natural Killer Cell-Secreted IFN-γ and TNF-α Mediated Differentiation in Lung Stem-like Tumors, Leading to the Susceptibility of the Tumors to Chemotherapeutic Drugs. [PDF]
Kaur K, Celis AP, Jewett A.
europepmc +1 more source
Effect of delayed isolation of peripheral blood mononuclear cells on cell viability and functionality. [PDF]
Lehle S+11 more
europepmc +1 more source
Short-term oral zinc supplementation enhances Natural Killer cell functionality and decreases circulating Innate Lymphoid Cell counts and frequencies in healthy young adults. [PDF]
Amling L, Rink L, Bennstein SB.
europepmc +1 more source
TP53‐Mutated Myeloid Neoplasms: 2024 Update on Diagnosis, Risk‐Stratification, and Management
ABSTRACT Alterations in the tumor suppressor gene TP53 are common in human cancers and are associated with an aggressive nature. Approximately 8%–12% of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) harbor TP53 mutations (TP53mut) and present immense challenges due to inherent chemoresistance and poor outcomes.
Mithun Vinod Shah+2 more
wiley +1 more source
NK Count and Natural Cytotoxicity in Immune Nonresponders Versus Responders Living With HIV. [PDF]
Silvestre C+8 more
europepmc +1 more source